论文部分内容阅读
目的探讨阿克他利治疗类风湿关节炎患者的临床疗效。方法选取2013年7月至2014年6月武警德宏边防支队医院收治的类风湿关节炎患者资料70例,按随机数字表法将其分为对照组和观察组,各35例。对照组患者口服甲氨蝶呤片,观察组患者采用阿克他利治疗。比较两组患者的临床疗效。结果观察组患者总有效率为94.3%,明显高于对照组的77.1%,差异有统计学意义(P<0.05);治疗后两组患者各项症状指标均明显改善,差异均有统计学意义(均P<0.05);观察组患者的不良反应发生率为8.6%,明显低于对照组的31.4%,差异有统计学意义(P<0.05)。结论应用阿克他利治疗类风湿关节炎患者临床疗效明显,不良反应少。
Objective To investigate the clinical efficacy of acterex in patients with rheumatoid arthritis. Methods Seventy patients with rheumatoid arthritis admitted to Dehong Border Defense Detachment Hospital of Armed Police Force from July 2013 to June 2014 were selected and randomly divided into control group and observation group with 35 cases in each group. Patients in the control group were treated with methotrexate orally, and patients in the observation group were treated with acterex. The clinical efficacy of the two groups was compared. Results The total effective rate of the observation group was 94.3%, which was significantly higher than that of the control group (77.1%), the difference was statistically significant (P <0.05); after treatment, the symptoms of both groups were significantly improved, the differences were statistically significant (All P <0.05). The adverse reaction rate in the observation group was 8.6%, which was significantly lower than that in the control group (31.4%, P <0.05). Conclusion The application of actelic acid in patients with rheumatoid arthritis clinical efficacy, adverse reactions less.